Bioregen Biomedical Changzhou competitive analysis

Loading summary...

Explore Bioregen Biomedical Changzhou's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jan 3, 2018Injectable In-Situ Crosslinked Hydrogel And The Preparation Method And Use Thereof1

Latest publications and patents of Bioregen Biomedical Changzhou New

Explore the latest publications and patents granted to Bioregen Biomedical Changzhou, showcasing their recent innovations and technological advancements.

Last updated on: Oct 20, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Bioregen Biomedical Changzhou

Jan 3, 2018Injectable In-Situ Crosslinked Hydrogel And The Preparation Method And Use ThereofOpposition Rejected

Latest PTAB cases involving Bioregen Biomedical Changzhou

Discover the latest PTAB cases involving Bioregen Biomedical Changzhou, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Bioregen Biomedical Changzhou with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BIOREGEN BIOMEDICAL CHANGZHOU - 1 - -
CROMA PHARMA GESELLSCHAFT2 - - -